IRF-2 Polyclonal Antibody, 100ul Cryogenic Vials and inhibited by GTPase activating

and inhibited by GTPase activating proteins (GAPs)

site 1) encodes a member of the subtilisin-like proprotein convertase family

It has been identified that genetic variation in this gene plays a role in the determination of bone mineral density (BMD)

The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance

IRF-2 Polyclonal Antibody, 100ul Cryogenic Vials and inhibited by GTPase activatingIRF2 encodes interferon regulatory factor 2, a member of the interferon regulatory transcription factor (IRF) family. IRF2 competitively inhibits the IRF1 mediated transcriptional activation of interferons alpha and beta, and presumably other genes that employ IRF1 for transcription activation. However, IRF2 also functions as a transcriptional activator of histone H4.